Antibiotic Chloramphenicol degradation using submerged thermal plasma synergized with LaMnO3 catalyst

Abstract

The present study focused on the degradation of antibiotic Chloramphenicol (CAP), an emerging contaminant, using submerged thermal plasma (STP) technology. Almost 99 % degradation and 82 % mineralization were achieved within 20 min of treatment by Ar/CO2 plasma, generated at 6.2 kW discharge power using a customized thermal plasma torch inside the aqueous solution. Kinetic analysis revealed first-order reaction for CAP degradation with a rate constant of 0.257 min−1. Long-lived species, such as H2O2, O3, NO2–, NO3–, and Cl- formed during plasma treatment were quantified. LaMnO3 perovskite (LMO) nanopowder prepared through a novel thermal plasma route, was introduced as catalyst into the treatment system which enhanced the degradation and mineralization efficiency by 34 % and 17 %, respectively, showing a strong synergetic effect between STP and catalyst. The energy yield was elevated from 102 mg/kWh to 144 mg/kWh with the addition of catalyst into the STP treatment system. Liquid chromatography-mass spectroscopy was used to identify the various degradation intermediates produced during thermal plasma treatment and correspondingly possible degradation pathways were proposed. The antibacterial activity assessment results revealed a significant reduction in the antimicrobial activity of all treated solutions against Gram-positive Bacillus cereus and Gram-negative Pseudomonas aeruginosa bacteria. Additionally, seed germination and growth assessment revealed a reduction in phytotoxicity of the treated solutions. STP, combined with the LMO, proved highly effective in treating pharmaceutical contamination in aqueous medium.